Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting the Future of Axillary Staging in Node Positive Breast Cancer Patients Receiving Primary Systemic Therapy. A Comparative Study Between Sentinel Node Biopsy vs PET/MRI.

NCT04826211 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT04826211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04826211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting the Future of Axillary Staging in Node Positive Breast Cancer Patients Receiving Primary Systemic Therapy. A Comparative Study Between Sentinel Node Biopsy vs PET/MRI.
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Completed
Start date
November 4, 2019
Completion date
December 31, 2024
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, node-positive breast cancer, sentinel lymph node